Temporal Increases in Subclinical Levels of Inflammation Are Associated With Adverse Clinical Outcomes in Patients With Left Ventricular Dysfunction

Journal of Cardiac Failure

Volumn 12, Issue 5, 2006, Pages 353-359

  De Denus, Simon ^a,b   White, Michel ^b   Tardif, Jean Claude ^b   Bourassa, Martial G ^b   Racine, Normand ^b   Levesque, Sylvie ^b   Ducharme, Anique ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Heart failure; Neutrophil; White blood cell

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL COUNT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; BLOOD CELL COUNT; CARDIOVASCULAR DISEASES; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33744515310     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.02.014     Document Type: Article

References (44)

1. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
2. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
3. Mann D.L. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail Rev 6 (2001) 71-80
4. Wollert K.C., and Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev 6 (2001) 95-103
5. Yin W.H., Chen J.W., Jen H.L., Chiang M.C., Huang W.P., Feng A.N., et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 147 (2004) 931-938
6. Alonso-Martinez J.L., Llorente-Diez B., Echegaray-Agara M., Olaz-Preciado F., Urbieta-Echezarreta M., and Gonzalez-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 4 (2002) 331-336
7. Cooper H.A., Exner D.V., Waclawiw M.A., and Domanski M.J. White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol 84 (1999) 252-257
8. Shehab A.M., MacFadyen R.J., McLaren M., Tavendale R., Belch J.J., and Struthers A.D. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart 90 (2004) 1263-1268
9. The SOLVD Investigators. Studies of left ventricular dysfunction (SOLVD)-rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 66 (1990) 315-322
10. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325 (1991) 293-302
11. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327 (1992) 685-691
12. Jordan M.R. Hematology: red and white blood cell tests. In: Traub S.L. (Ed). Basic skills in interpreting laboratory data (1996), American Society of Health-System Pharmacists, Bethesda, MD 297-320
13. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
14. Wheeler J.G., Mussolino M.E., Gillum R.F., and Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 25 (2004) 1287-1292
15. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44 (2004) 1945-1956
16. Tsuyuki R.T., McKelvie R.S., Arnold J.M., Avezum Jr. A., Barretto A.C., Carvalho A.C., et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 161 (2001) 2337-2342
17. Ommen S.R., Hammill S.C., and Gibbons R.J. The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators. Pacing Clin Electrophysiol 25 (2002) 1424-1428
18. Ommen S.R., Hodge D.O., Rodeheffer R.J., McGregor C.G., Thomson S.P., and Gibbons R.J. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 97 (1998) 19-22
19. Sakatani T., Hadase M., Kawasaki T., Kamitani T., Kawasaki S., and Sugihara H. Usefulness of the percentage of plasma lymphocytes as a prognostic marker in patients with congestive heart failure. Jpn Heart J 45 (2004) 275-284
20. Acanfora D., Gheorghiade M., Trojano L., Furgi G., Pasini E., Picone C., et al. Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J 142 (2001) 167-173
21. Gillum R.F., Mussolino M.E., and Madans J.H. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 15 (2005) 266-271
22. Prasad K., Kalra J., Massey K.L., and Bharadwaj B. Increased production of oxygen free radicals by polymorphonuclear leukocytes in heart failure due to aortic stenosis. Angiology 40 (1989) 472-478
23. Prasad K., Kalra J., and Bharadwaj B. Increased chemiluminescence of polymorphonuclear leucocytes in dogs with volume overload heart failure. Br J Exp Pathol 70 (1989) 463-468
24. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61 (2004) 481-497
25. White M., Rouleau J.L., Ruddy T.D., De Marco T., Moher D., and Chatterjee K. Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. J Am Coll Cardiol 18 (1991) 1631-1637
26. Parodi O., De Maria R., Oltrona L., Testa R., Sambuceti G., Roghi A., et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 88 (1993) 509-522
27. Neglia D., Parodi O., Gallopin M., Sambuceti G., Giorgetti A., Pratali L., et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation 92 (1995) 796-804
28. Neglia D., Michelassi C., Trivieri M.G., Sambuceti G., Giorgetti A., Pratali L., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105 (2002) 186-193
29. Ellis G.R., Anderson R.A., Lang D., Blackman D.J., Morris R.H., Morris-Thurgood J., et al. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. J Am Coll Cardiol 36 (2000) 1474-1482
30. Witko-Sarsat V., Rieu P., Descamps-Latscha B., Lesavre P., and Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 80 (2000) 617-653
31. Moskowitz R., and Kukin M. Oxidative stress and congestive heart failure. Congest Heart Fail 5 (1999) 153-163
32. Mak S., and Newton G.E. The oxidative stress hypothesis of congestive heart failure: radical thoughts. Chest 120 (2001) 2035-2046
33. Siwik D.A., Pagano P.J., and Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280 (2001) C53-C60
34. Sugano R., Matsuoka H., Haramaki N., Umei H., Murase E., Fukami K., et al. Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies. Arterioscler Thromb Vasc Biol 25 (2005) 1262-1267
35. Kawakami R., Saito Y., Kishimoto I., Harada M., Kuwahara K., Takahashi N., et al. Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction. Circulation 110 (2004) 3306-3312
36. Lindsey M.L. MMP induction and inhibition in myocardial infarction. Heart Fail Rev 9 (2004) 7-19
37. Janicki J.S., Brower G.L., Gardner J.D., Chancey A.L., and Stewart Jr. J.A. The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling. Heart Fail Rev 9 (2004) 33-42
38. Poulsen S.H., Host N.B., Jensen S.E., and Egstrup K. Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation 101 (2000) 1527-1532
39. Zannad F., Alla F., Dousset B., Perez A., and Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 102 (2000) 2700-2706
40. Abdelhadi R.H., Gurm H.S., Van Wagoner D.R., and Chung M.K. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 93 (2004) 1176-1178
41. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
42. Korantzopoulos P., Kolettis T., Siogas K., and Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 9 (2003) 225-229
43. Sajadieh A., Nielsen O.W., Rasmussen V., Hein H.O., Abedini S., and Hansen J.F. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25 (2004) 363-370
44. Uretsky B.F., Thygesen K., Armstrong P.W., Cleland J.G., Horowitz J.D., Massie B.M., et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation 102 (2000) 611-616